Prostate Cancer News
Most Popular Prostate Cancer Story
Pfizer writes off $725M Dimebon pact after final Phase III failure
The last flickering hope that Medivation's Dimebon could help Alzheimer's disease patients has just been extinguished. The biotech announced this morning that a 12-month study of the drug failed to Read more...
Latest Headlines
- November 1, 2011
- September 26, 2011
- September 20, 2011
- September 20, 2011
- April 28, 2011
- March 16, 2011
- November 9, 2010
- October 11, 2010
- September 27, 2010
- February 17, 2010
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
